92 related articles for article (PubMed ID: 19899103)
1. N-malonyl-1,2-dihydroisoquinoline as a novel carrier for specific delivery of drugs to the brain.
Abdel-Aziz M; Abuo-Rahma Gel-D; Hassan HA; Farag HH
Arch Pharm (Weinheim); 2010 Jan; 343(1):54-60. PubMed ID: 19899103
[TBL] [Abstract][Full Text] [Related]
2. 1-Malonyl-1,4-dihydropyridine as a novel carrier for specific delivery of drugs to the brain.
Hassan HA; Abdel-Aziz M; Abuo-Rahma Gel-D; Farag HH
Bioorg Med Chem; 2009 Feb; 17(4):1681-92. PubMed ID: 19147368
[TBL] [Abstract][Full Text] [Related]
3. 1, 2-dihydroisoquinoline-N-acetic acid derivatives as new carriers for brain-specific delivery II: delivery of phenethylamine as model drug.
Mahmoud S; Sheha M; Aboul-Fadl T; Farag H
Arch Pharm (Weinheim); 2003 Jul; 336(4-5):258-63. PubMed ID: 12916061
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological investigation and molecular docking study of N-malonyl-1,2-dihydroisoquinoline derivatives as brain specific and shelf-stable MAO inhibitors.
Abd El-Gaber MK; Hassan HY; Mahfouz NM; Farag HH; Bekhit AA
Eur J Med Chem; 2015 Mar; 93():481-91. PubMed ID: 25732770
[TBL] [Abstract][Full Text] [Related]
5. 1, 2-dihydroisoquinoline-N-acetic acid derivatives as new carriers for specific brain delivery I: synthesis and estimation of oxidation kinetics using multivariate calibration method.
Mahmoud S; Aboul-Fadl T; Sheha M; Farag H; Mouhamed AM
Arch Pharm (Weinheim); 2003 Dec; 336(12):573-84. PubMed ID: 14677151
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brain.
El-Sherbeny MA; Al-Salem HS; Sultan MA; Radwan MA; Farag HA; El-Subbagh HI
Arch Pharm (Weinheim); 2003 Oct; 336(10):445-55. PubMed ID: 14582121
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, radiosynthesis and biological evaluation of 1,4-dihydroquinoline derivatives as new carriers for specific brain delivery.
Foucout L; Gourand F; Dhilly M; Bohn P; Dupas G; Costentin J; Abbas A; Marsais F; Barré L; Levacher V
Org Biomol Chem; 2009 Sep; 7(18):3666-73. PubMed ID: 19707670
[TBL] [Abstract][Full Text] [Related]
8. Brain delivery of HIV protease inhibitors.
Sheha MM; el-Koussi NA; Farag HH
Arch Pharm (Weinheim); 2003 Mar; 336(1):47-52. PubMed ID: 12666253
[TBL] [Abstract][Full Text] [Related]
9. Chemical delivery system of metaiodobenzylguanidine (MIBG) to the central nervous system.
Gourand F; Mercey G; Ibazizène M; Tirel O; Henry J; Levacher V; Perrio C; Barré L
J Med Chem; 2010 Feb; 53(3):1281-7. PubMed ID: 20085326
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a redox chemical delivery system for brain-enhanced dopamine containing an activated carbamate-type ester.
Omar FA; Farag HH; Bodor N
J Drug Target; 1994; 2(4):309-16. PubMed ID: 7858956
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, calcium channel antagonist activity, and anticonvulsant activity of felodipine coupled to a dihydropyridine-pyridinium salt redox chemical delivery system.
Yiu S; Knaus EE
J Med Chem; 1996 Nov; 39(23):4576-82. PubMed ID: 8917646
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluations of dihydroquinoline- and dihydroisoquinoline-based targetor moieties for brain-specific chemical delivery systems.
Bodor N; Farag HH; Barros MD; Wu WM; Buchwald P
J Drug Target; 2002 Feb; 10(1):63-71. PubMed ID: 11996088
[TBL] [Abstract][Full Text] [Related]
13. Improved delivery through biological membranes. XXI. Brain-targeted anti-convulsive agents.
Woodard PA; Winwood D; Brewster ME; Estes KS; Bodor N
Drug Des Deliv; 1990 May; 6(1):15-28. PubMed ID: 2078285
[TBL] [Abstract][Full Text] [Related]
14. Chemical delivery systems for drugs containing an amino group: synthesis and properties of some pyridine derivatives of desipramine.
Pop E; Wu WM; Shek E; Bodor N
Drug Des Deliv; 1989 Dec; 5(2):93-115. PubMed ID: 2577990
[TBL] [Abstract][Full Text] [Related]
15. Brain and CSF specific chemical delivery systems for beta-lactam antibiotics. Study of two dihydropyridine derivatives of benzylpenicillin in rabbits and dogs.
Wu WM; Pop E; Shek E; Clemmons R; Bodor N
Drug Des Deliv; 1990 Dec; 7(1):33-43. PubMed ID: 2096832
[TBL] [Abstract][Full Text] [Related]
16. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
17. Brain-specific chemical delivery systems for beta-lactam antibiotics. In vitro and in vivo studies of some dihydropyridine and dihydroisoquinoline derivatives of benzylpenicillin in rats.
Wu WM; Pop E; Shek E; Bodor N
J Med Chem; 1989 Aug; 32(8):1782-8. PubMed ID: 2754705
[TBL] [Abstract][Full Text] [Related]
18. Improved delivery through biological membranes. Synthesis, distribution, and neurochemical effects of a tryptamine chemical delivery system.
Bodor N; Nakamura T; Brewster ME
Drug Des Deliv; 1986 Aug; 1(1):51-64. PubMed ID: 3509320
[TBL] [Abstract][Full Text] [Related]
19. Improved delivery through biological membranes XXV. Enhanced and sustained delivery of trifluorothymidine to the brain using a dihydropyridine in equilibrium pyridinium salt type redox delivery system.
el-Koussi A; Bodor N
Drug Des Deliv; 1987 May; 1(4):275-83. PubMed ID: 3151241
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
